AJCN Cancer Health Disparities Conference
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Sun, Q.
Right arrow Articles by Hu, F. B
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sun, Q.
Right arrow Articles by Hu, F. B
Agricola
Right arrow Articles by Sun, Q.
Right arrow Articles by Hu, F. B
American Journal of Clinical Nutrition, Vol. 88, No. 1, 216-223, July 2008
© 2008 American Society for Nutrition

ORIGINAL RESEARCH COMMUNICATION

Blood concentrations of individual long-chain n–3 fatty acids and risk of nonfatal myocardial infarction1,2,3

Qi Sun, Jing Ma, Hannia Campos, Kathryn M Rexrode, Christine M Albert, Dariush Mozaffarian and Frank B Hu

1 From the Departments of Nutrition (QS, HC, and FBH) and Epidemiology (DM and FBH), Harvard School of Public Health, Boston, MA, and the Channing Laboratory (JM, DM, and FBH), the Division of Cardiovascular Medicine (CMA and DM), and the Division of Preventive Medicine (KMR and CMA), Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA

Background: Whereas dietary intake of long-chain n–3 fatty acids has been associated with risk of nonfatal myocardial infarction (MI), few studies have examined the relation for blood concentrations.

Objective: We aimed to investigate the effect of long-chain n–3 fatty acids in blood on the risk of nonfatal MI.

Design: Baseline blood samples were collected from 32 826 participants of the Nurses' Health Study in 1989–1990, among whom 146 incident cases of nonfatal MI were ascertained during 6 y of follow-up and matched with 288 controls.

Results: After multivariate adjustment, the relative risks (95% CI) comparing the highest with the lowest quartiles in plasma were 0.23 (0.09, 0.55; P for trend = 0.001) for eicosapentaenoic acid (EPA), 0.40 (0.20, 0.82; P for trend = 0.004) for docosapentaenoic acid (DPA), and 0.46 (0.18, 1.16; P for trend = 0.07) for docosahexaenoic acid (DHA). The associations for these fatty acids in erythrocytes were generally weaker and nonsignificant. In contrast to EPA and DHA, blood concentrations of DPA were not correlated with dietary consumption of n–3 fatty acids. Higher plasma concentrations of EPA, DPA, and DHA were associated with higher plasma concentrations of HDL cholesterol and lower concentrations of triacylglycerol and inflammatory markers.

Conclusions: Higher plasma concentrations of EPA and DPA are associated with a lower risk of nonfatal MI among women. These findings may partly reflect dietary consumption but, particularly for DPA, may indicate important risk differences based on metabolism of long-chain n–3 fatty acids.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by The American Society for Nutrition